News
Guselkumab found promising for Crohn’s in phase 2 study
- Author:
- Brandon May
Conventional first-line therapies for Crohn’s disease often are not effective for maintaining clinical remission and are associated with...
News
Registry data support lowering CRC screening age to 45
- Author:
- Brandon May
Existing research gaps on the rates of younger-onset colorectal neoplasia need to be addressed to support these recommendations.
News
Cryoballoon ablation demonstrates long-term durability in BE
- Author:
- Brandon May
Despite its utility, few data are available to describe the durability of the cryoballoon ablation’s effects for Barrett’s esophagus.
News
Registry data support lowering CRC screening age to 45
- Author:
- Brandon May
Existing research gaps on the rates of younger-onset colorectal neoplasia need to be addressed to support these recommendations.
News
Improved follow-up needed to find late-stage pancreatic cancers
- Author:
- Brandon May
Factors associated with detecting late-stage pancreatic ductal adenocarcinomas during this follow-up are hard to pin down.
News
Improved follow-up needed to find late-stage pancreatic cancers
- Author:
- Brandon May
Factors associated with detecting late-stage pancreatic ductal adenocarcinomas during this follow-up are hard to pin down.
News
ACE index predicts steroid response in acute severe UC
- Author:
- Brandon May
The ACE index shows promise for earlier prediction of steroid nonresponse in patients with acute severe UC.
News
Real-world practice informs tofacitinib use in UC
- Author:
- Brandon May
Real-world data and practice observations provide further insight into the effective use of the JAK inhibitor in moderate-to-severe UC.
News
Vedolizumab does not increase risk of C. diff infection in UC
- Author:
- Brandon May
Vedolizumab’s effects in the intestines have led to concerns that the antibody could increase the risk of C. difficile infection in...
News
Vedolizumab does not increase risk of C. diff infection in UC
- Author:
- Brandon May
Vedolizumab’s effects in the intestines have led to concerns that the antibody could increase the risk of C. difficile infection in...
News
Few patients with IBD receive early vedolizumab
- Author:
- Brandon May
Earlier treatment is associated with increased likelihood of response and remission, but in clinical practice, biologic agents are often delayed...
News
AI system improves early gastric cancer detection
- Author:
- Brandon May
Gastric cancer detection practices vary considerably across providers, creating the need for objective, consistent approaches to earlier detection...
News
Hemostatic powder noninferior in nonvariceal upper GI bleeds
- Author:
- Brandon May
TC-325 hemostatic powder compares well with standard endoscopic treatment of acute nonvariceal gastrointestinal bleeding in a new study.
News
ESD vs. cEMR: Rates of complete remission in Barrett’s compared
- Author:
- Brandon May
The study found similar rates of complete remission of intestinal metaplasia between the ESD and cEMR treatment groups at 2 years.
News
COVID-19 vaccines: Lower serologic response among IBD, rheumatic diseases
- Author:
- Brandon May
Patients with immune-mediated inflammatory diseases urged to get full mRNA vaccine series without delay and possibly a third dose.